Tawnya L Bowles

Tawnya L Bowles

UNVERIFIED PROFILE

Are you Tawnya L Bowles?   Register this Author

Register author
Tawnya L Bowles

Tawnya L Bowles

Publications by authors named "Tawnya L Bowles"

Are you Tawnya L Bowles?   Register this Author

19Publications

444Reads

37Profile Views

Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011).

J Am Acad Dermatol 2018 Aug 1;79(2):238-244. Epub 2018 Mar 1.

Department of Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah; George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2018.02.055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754624PMC
August 2018

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.

N Engl J Med 2017 06;376(23):2211-2222

From the John Wayne Cancer Institute at Saint John's Health Center, Santa Monica (M.B.F., D.S.B.H.), and the Departments of Pathology (A.J.C.), Biomathematics (H.-J.W., D.A.E., R.M.E.), and Medicine (D.A.E.), University of California, Los Angeles - both in California; Melanoma Institute Australia and the University of Sydney, Sydney (J.F.T., O.E.N.), Peter MacCallum Cancer Centre, Melbourne, VIC (M.H.), Princess Alexandra Hospital, Brisbane, QLD (B.M.S.), and Newcastle Melanoma Unit, Waratah, NSW (P.H.) - all in Australia; Huntsman Cancer Institute, Salt Lake City (R.H.A., R.D.N.), and Intermountain Healthcare Cancer Services-Intermountain Medical Center, Murray (T.L.B.) - both in Utah; Istituto Nazionale dei Tumori Napoli, Naples (N.M.), Istituto Europeo di Oncologia, Milan (A.T.), and Istituto Oncologico Veneto-University of Padua, Padua (C.R.R.) - all in Italy; H. Lee Moffitt Cancer Center, Tampa, FL (J.S.Z.); Helsinki University Hospital, Helsinki (T.J.); Dallas Surgical Group, Dallas (P.D.B.); Universitair Medisch Centrum Groningen, Groningen (H.J.H.), and Netherlands Cancer Institute, Amsterdam (M.W.J.M.W.) - both in the Netherlands; Norfolk and Norwich University Hospital, Norwich (M. Moncrieff), and Guy's and St. Thomas' NHS Foundation Trust, London (A.M.-R.) - both in the United Kingdom; Swedish Melanoma Study Group-University Hospital Lund, Lund, Sweden (C.I.); University of Michigan, Ann Arbor (M.S.S.); Wake Forest University, Winston-Salem (E.A.L.), and Duke University, Durham (R.S.) - both in North Carolina; Ohio State University, Columbus (D.A.); University of Zurich, Zurich (R.D.), and Centre Hospitalier Universitaire Vaudois, Lausanne (M. Matter) - both in Switzerland; Penn State Hershey Cancer Institute, Hershey (R.I.N.), Thomas Jefferson University (A.C.B.) and Fox Chase Cancer Center (J.M.F.), Philadelphia, and St. Luke's University Health Network, Bethlehem (D.C.D.) - all in Pennsylvania; Greenville Health System Cancer Center, Greenville, SC (S.D.T.); Sunnybrook Research Institute, Toronto (F.W.), and Tom Baker Cancer Centre, Calgary, AB (G.M.) - both in Canada; University of Washington, Seattle (D.R.B.); Saint Louis University, St. Louis (E.H.); Vanderbilt University (D.B.J., M.C.K.), Nashville, and University of Tennessee, Knoxville (J.M.L.) - both in Tennessee; University Hospital Schleswig-Holstein-Campus Lübeck, Lübeck (P.T.), University Hospital of Würzburg, Würzburg (A.G.), and City Hospital of Nürnberg, Nuremberg (E.S.) - all in Germany; SUNY at Stony Brook Hospital Medical Center, Stony Brook (T.L.H.), Memorial Sloan Kettering Cancer Center, New York (C.E.A.), and Roswell Park Cancer Institute, Buffalo (J.M.K.) - all in New York; Northwestern University Feinberg School of Medicine (J.D.W.) and Rush University Medical Center (S.D.B.), Chicago; University of Wisconsin, Madison (H.B.N.); Tel Aviv Sourasky Medical Center, Tel Aviv, Israel (S.S.); M.D. Anderson Medical Center, Houston (J.E.G.); Johns Hopkins University School of Medicine, Baltimore (L.J.); University of Louisville, Louisville, KY (K.M.M.); Dartmouth-Hitchcock Medical Center, Lebanon, NH (R.J.B.); Hospital Clinic Barcelona, Barcelona (S.V.-S.); and Sentara CarePlex Hospital, Hampton, VA (R.A.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1613210DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548388PMC
June 2017

Malignant melanoma scrotal metastasis: The importance of the genital examination.

JAAD Case Rep 2017 Jan 23;3(1):10-12. Epub 2016 Dec 23.

Melanoma and Cutaneous Oncology Program, Huntsman Cancer Institute, University of Utah and Intermountain Health Care, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdcr.2016.09.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198856PMC
January 2017

Recurrent cutaneous angiosarcoma of the ear masquerading as atypical fibroxanthoma.

JAAD Case Rep 2016 Nov 5;2(6):445-447. Epub 2016 Dec 5.

Melanoma and Cutaneous Oncology Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; Intermountain Health Care, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdcr.2016.09.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148779PMC
November 2016

An individualized conditional survival calculator for patients with rectal cancer.

Dis Colon Rectum 2013 May;56(5):551-9

Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DCR.0b013e31827bd287DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673550PMC
May 2013

Sentinel lymph node biopsy for melanoma in pregnant women.

Ann Surg Oncol 2013 Feb 6;20(2):689-96. Epub 2012 Oct 6.

Melanoma and Cutaneous Oncology Program, Huntsman Cancer Institute, University of Utah and Intermountain Health Care, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1245/s10434-012-2633-7
Publisher Site
http://dx.doi.org/10.1245/s10434-012-2633-7DOI Listing
February 2013

The role of Akt activation in the response to chemotherapy in pancreatic cancer.

Anticancer Res 2010 Sep;30(9):3279-89

Department of Surgery, University of California, Davis Medical Center, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557882PMC
September 2010

Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease.

Ann Surg Oncol 2010 Aug 6;17(8):2015-23. Epub 2010 Apr 6.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-010-1051-yDOI Listing
August 2010

ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis.

J Surg Res 2009 Mar 11;152(1):18-25. Epub 2008 Jun 11.

Division of Surgical Oncology, Department of Surgery, University of California Davis Medical Center, Sacramento, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jss.2008.05.017DOI Listing
March 2009

Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis.

Cancer Res 2009 Jan;69(2):700-8

Department of Biological Chemistry, Division of Surgical Oncology, Center for Biophotonics and Science Technology, University of California at Davis, Sacramento, California 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-3157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629384PMC
January 2009

Experience and attitudes of surgeons toward palliation in cancer.

Arch Surg 2005 Sep;140(9):873-8; discussion 878-80

Department of Surgery, University of California, Davis, Medical Center, Sacramento 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archsurg.140.9.873DOI Listing
September 2005